Brief: LifeTech Scientific Updates On Concave Supra-Arch Branched Stent-Graft System
Jan 12 (Reuters) - LifeTech Scientific Corp 1302.HK: CONCAVE SUPRA-ARCH BRANCHED STENT-GRAFT SYSTEM ADMITTED INTO NMPA SPECIAL EXAMINATION AND APPROVAL PROCEDURE Further company coverage: 1302.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on LifeTech Scientific
See all newsBrief: Lifetech Scientific's Ics Elpis Admitted To Nmpa Special Examination On October 19, 2026
Brief: Lifetech Scientific Says Surechamtm Stent Graft Admitted To Nmpa Special Examination And Approval Procedure
Brief: Lifetech Scientific Expects Net Profit Attributable For Six Months Ended June 2026
Brief: Lifetech Scientific To Not Proceed With Major Deal
Brief: Lifetech Scientific To Buy 96.46% Of Starway Medical Technology